Cleveland、OHにおける肺がんの臨床試験
Clevelandとその周辺地域（約30マイル以内）の拠点で、肺がんに関する26件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
The Vanguard Study: Testing a New Way to Screen for Cancer
被験者募集中健康なボランティア歓迎
- Louis Stokes Cleveland VA Medical Center, Cleveland
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
被験者募集中第3相
- Case Western Reserve University, Cleveland
- MetroHealth Medical Center, Cleveland
- UHHS-Chagrin Highlands Medical Center, Beachwood · 10マイル先
- 他1件
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
被験者募集中第3相
- MetroHealth Medical Center, Cleveland
- Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
- Cleveland Clinic Foundation, Cleveland
- 他2件
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
被験者募集中第3相
- Case Western Reserve University, Cleveland
- Cleveland Clinic Foundation, Cleveland
- UHHS-Chagrin Highlands Medical Center, Beachwood · 10マイル先
- 他2件
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
被験者募集中第1/2相
- The Cleveland Clinic Taussig Cancer Center, Cleveland
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
被験者募集中第3相
- University Hospitals Cleveland Medical Center, Cleveland
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
被験者募集中第3相
- University Hospitals Cleveland Medical Center, Cleveland
- UH Minoff Health Center at Chagrin Highlands, Orange · 12マイル先
- University Hospitals Seidman Cancer Center at UH Mentor Health Center, Mentor · 22マイル先
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
被験者募集中第1/2相
- Cleveland Clinic, Cleveland
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
被験者募集中第2相
- Research Site, Cleveland
Pulmonary Rehabilitation in Advanced Lung Cancer Survivors
被験者募集中第2相
- University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
被験者募集中第2/3相
- The Cleveland Clinic Cancer Center At Fairview Hospital, Moll Pavilion, Cleveland
- Cleveland Clinic, Cleveland
- Cleveland Clinic - Hillcrest Hospital, Mayfield Heights · 12マイル先
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
被験者募集中第2/3相
- University Hospitals Cleveland Medical Center, Cleveland
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
被験者募集中第1/2相
- Case Western Reserve University, Cleveland
A Study Evaluating a New Radiation Treatment Workflow (NGDS)
被験者募集中
- University Hospital Cleveland Medical Center, Cleveland
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
被験者募集中第1/2相
- Cleveland Clinic, Cleveland
Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation
被験者募集中第1/2相
- Case Western Reserve University, Cleveland
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
被験者募集中第1相
- Cleveland Clinic, Cleveland
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
被験者募集中第3相
- University Hospitals Cleveland Medical Center, Cleveland
- The Cleveland Clinic Cancer Center at Fairview Hospital, Moll Pavilion, Cleveland
- Cleveland Clinic Foundation, Cleveland
- 他1件
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
被験者募集中第3相
- Case Western Reserve University, Cleveland
- UHHS-Chagrin Highlands Medical Center, Beachwood · 10マイル先
- UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor · 22マイル先
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
被験者募集中第1相
- University Hospital - Cleveland Medical Center, Cleveland
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
被験者募集中第1/2相
- University Hospitals Cleveland Medical Center, Cleveland
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
被験者募集中観察研究
- University Hospitals Seidman Cancer Center, Cleveland
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
被験者募集中
- Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
被験者募集中観察研究健康なボランティア歓迎
- Cleveland Clinic, Cleveland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, Mayfield Heights · 12マイル先
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
被験者募集中第1/2相
- Cleveland Clinic, Cleveland
他の都市における肺がんの試験
- Houston, TX78件の研究
- Boston, MA62件の研究
- New York City, NY60件の研究
- Los Angeles, CA45件の研究
- Arlington, VA41件の研究
- Washington, DC41件の研究
- Chicago, IL41件の研究
- Baltimore, MD40件の研究
- Nashville, TN40件の研究
- St. Louis, MO39件の研究
- Columbus, OH37件の研究
- Philadelphia, PA36件の研究
Clevelandにおける他の研究
- 非小細胞肺癌43件の研究
- がん（全種類）36件の研究
- 乳がん35件の研究
- 前立腺がん34件の研究
- 心不全33件の研究
- 卵巣がん30件の研究
- 転移性癌30件の研究
- 大腸癌24件の研究
- 心血管疾患22件の研究
- 子宮内膜がん20件の研究
- 急性骨髄性白血病20件の研究
- クローン病19件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。